Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01501526
Other study ID # DMR100-IRB-190
Secondary ID
Status Recruiting
Phase N/A
First received December 25, 2011
Last updated December 28, 2011
Start date October 2011
Est. completion date March 2012

Study information

Verified date December 2011
Source China Medical University Hospital
Contact Teik Ying Ng
Phone 886975681139
Email u702131@yahoo.com.tw
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Observational

Clinical Trial Summary

Herpes esophagitis presents a clinical diagnostic challenge. The investigators report the first case of herpes esophagitis presenting as vocal fold palsy in an immunocompetent host. The investigators case highlights the importance of performing a detailed laryngoscopic examination in any patient with prolonged husky voice.


Recruitment information / eligibility

Status Recruiting
Enrollment 1
Est. completion date March 2012
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 50 Years to 55 Years
Eligibility Inclusion Criteria:

- Patient of Herpes esophagitis with vocal palsy presentation

Exclusion Criteria:

- Patient of Herpes esophagitis without vocal palsy presentation

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Locations

Country Name City State
Taiwan China Medical University Hospital Taichung

Sponsors (1)

Lead Sponsor Collaborator
China Medical University Hospital

Country where clinical trial is conducted

Taiwan, 

See also
  Status Clinical Trial Phase
Completed NCT05747859 - Voice Telerehabilitation
Recruiting NCT04700566 - Allograft Adipose Injectable for Vocal Fold Paralysis Phase 3
Completed NCT04315415 - A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid N/A
Completed NCT03882450 - Universal Screening for Vocal Fold Motion Impairment in Children Undergoing Congenital Cardiac Surgery N/A
Completed NCT04764604 - Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment N/A